BD Ultra-Fine II® Insulin Syringes for Comfortable, Precise Dosing

What BD Ultra-Fine II® Is and How It Works

BD Ultrafine II Insulin Syringes are single-use, sterile U-100 syringes designed for subcutaneous insulin delivery. They are available in common capacities (0.3 mL, 0.5 mL, and 1 mL) with easy-to-read unit markings for accurate dosing. Many patients choose bd ultra fine ii short needle insulin syringes for comfort and consistent injections. YouDrugstore is a licensed Canadian pharmacy headquartered in Manitoba; prescriptions are reviewed by licensed pharmacists before dispensing. We offer brand and generic medicines at Canadian prices and also carry OTC health products.

These syringes use thin-wall, siliconized needles to help the needle glide smoothly through the skin. Short 8 mm options support a 90-degree technique for many users, and longer 12.7 mm options are also available for specific needs. Clear barrels and bold graduations help confirm the correct dose at a glance. The fine needle and lubricant coating aim to reduce insertion force and improve comfort.

BD Ultra-Fine II syringes work with U-100 insulin vials for basal, prandial, or correction doses as directed by a prescriber. The lineup includes options with half-unit markings (on select 0.3 mL sizes) to support small adjustments. These features make bd ultra fine 2 insulin syringes a dependable choice for consistent daily care.

To maintain a broad selection with affordable pricing, we partner with licensed, vetted international pharmacies so you receive authentic brand supplies at fair, transparent costs.

Dosage and Usage

• Wash hands and assemble supplies: insulin vial, syringe, alcohol swab, and a sharps container.
• Confirm U-100 compatibility. Choose 0.3 mL (up to 30 units), 0.5 mL (up to 50 units), or 1 mL (up to 100 units) based on the prescribed dose.
• For cloudy insulin, gently roll the vial between the palms per product instructions.
• Draw air into the syringe equal to the intended dose. Insert the needle into the vial and push air in.
• Invert the vial and withdraw the dose. Tap the syringe to move bubbles to the top, then push out air. Recheck the dose at eye level.
• Select an injection site: abdomen, thigh, upper outer arm, or buttock. Rotate sites to reduce skin changes.
• Clean the site with an alcohol swab and let it dry. Insert the needle into the subcutaneous tissue.
• Use a steady push on the plunger. After injecting, wait a few seconds before withdrawing the needle.
• Do not recap. Place the used syringe directly into a puncture-resistant sharps container.
• If a scheduled injection is missed, follow the diabetes care plan provided by the prescriber or clinic.

• Store your syringes at room temperature, ideally 15–25 °C (59–77 °F), in their original packaging.
• Keep your supplies dry and away from direct sunlight or extreme heat. Do not freeze or attempt to resterilize.
• Open a sterile wrapper only when you are ready to inject. Do not use a bent or damaged needle.
• When you travel, pack extra syringes in your carry-on with insulin and a sharps container or travel-safe receptacle.
• Carry a copy of your medication list or prescription if required by airport security. Keep syringes out of reach of children.

Benefits and Savings

BD Ultra-Fine II syringes are engineered for comfort, clarity, and accuracy. The thin-wall design helps insulin flow with less plunger force. Short 8 mm needles can support a straight 90-degree technique for many body types, and bold unit markings help confirm dosing. Options with half-unit markings assist with small dose adjustments when prescribed.

These syringes are compatible with U-100 insulin vials used in basal-bolus and other regimens. Many users value the flexibility of adjusting doses as directed by their clinician. Clear packaging, color-coding, and multiple capacities make it easy to match the correct syringe to the prescribed dose.

Ordering from Canada can lower costs. Typical US shoppers save about 60–80% compared with common US retail prices. Multi-month packs can reduce per-month costs, and you can set simple reorder reminders so you do not run short of supplies.

Side Effects and Safety

• Mild pain or stinging at the injection site
• Small drop of blood or bruising at the site
• Redness, tenderness, or swelling where the needle entered
• Temporary skin irritation
• Occasional bent needle or difficult insertion if technique or site is not optimal

Serious effects are uncommon but can include infection at the injection site or significant bleeding. Lipohypertrophy or lipoatrophy can occur with poor rotation of sites. Used needles can cause needlestick injuries if handled improperly. Insulin itself can cause hypoglycemia, especially if combined with insulin secretagogues such as sulfonylureas; prescribers often adjust doses to reduce this risk. Seek medical advice promptly for signs of infection, spreading redness, fever, or severe pain.

Onset Time

A syringe injection delivers insulin into the fatty layer under the skin within seconds. The metabolic effect depends on the insulin formulation:

Rapid-acting insulin often starts to lower glucose in about 10–30 minutes, with a peak around 1–3 hours. Short-acting insulin may begin working in 30–60 minutes and peaks later. Intermediate-acting insulin often starts in 1–2 hours. Long-acting basal insulin can take several hours to reach steady activity. Proper subcutaneous placement with BD Ultra-Fine II syringes supports each insulin’s expected onset and action profile.

Compare With Alternatives

Pen users may prefer needle tips designed for injection pens. If a prescriber has moved therapy to pens, consider BD® Nano Pro Pen Needles Ultrafine for comfortable pen dosing. These are not for vials and syringes, but they can simplify injections for those on pen-based regimens.

Some long-acting insulins and mealtime insulins are available in cartridges or prefilled pens. For example, Levemir® Penfill Cartridges pair with compatible pen devices to simplify daily dosing and reduce supply handling. Pen systems offer convenience, while syringes offer flexibility with vial-based insulin and small dose adjustments.

Fixed-ratio combinations in pens, such as Xultophy® Prefilled Pen, combine basal insulin with a GLP-1 receptor agonist for eligible patients. These products are pen-only and do not use syringes; the choice depends on clinical goals, dose precision needs, and prescriber guidance.

Combination Therapy

• Basal insulin once daily plus rapid-acting insulin for meals using syringes and vials
• Basal or prandial insulin with a GLP-1 receptor agonist; clinicians may adjust doses to limit hypoglycemia
• Insulin plus a sulfonylurea; dose adjustments are often used to lower hypoglycemia risk
• Use alongside CGM or capillary glucose monitoring for dose decisions directed by a healthcare professional

Patient Suitability and Cost-Saving Tips

These syringes suit people who use U-100 insulin from vials and need precise dose control. They are not intended for use with pen cartridges or prefilled pens, and they are not for intravenous or intramuscular use. Those with vision or dexterity challenges may need training, adaptive tools, or a switch to pen devices as guided by a clinician.

Choose 0.3 mL, 0.5 mL, or 1 mL syringes to match typical doses and reduce measurement error. Short 8 mm options can support a 90-degree technique for many users; clinicians can advise on site and angle for individual needs. Never share or reuse these single-use syringes. Always place used needles in a sharps container immediately after injection.

To manage costs, order a multi-month supply when appropriate. Bulk packs often lower the cost per month, and you can activate simple reminders to reorder before your supply runs low. Prompt, express shipping helps you stay stocked without last-minute pharmacy trips.

Authoritative Sources

BD manufacturer: Ultra-Fine insulin syringes overview

FDA: Safe sharps disposal guidance

Health Canada: Safe disposal of needles and syringes

Order BD Ultra-Fine II® from YouDrugstore: add to cart, and we ship with prompt, express handling.

This page is for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always follow the guidance of your healthcare provider for insulin selection, dosing, and injection technique.